Akèy › Maladi atè koronè › Kalifòni

Etid klinik pou Maladi atè koronè nan Kalifòni

23 etid pou Maladi atè koronè ap chèche patisipan nan sit nan Kalifòni.

Vil nan Kalifòni

Tèks ofisyèl etid la (Anglè)

Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)

Loma Linda University Medical Center, Loma Linda
UC Davis, Sacramento
Los Robles Regional Medical Center, Thousand Oaks

Ap rekrite

Laj 18 a 90 · Tout sèks · Mizajou Sep 30, 2026 · NCT07296744

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

Pacific Oaks Medical Group, Beverly Hills
Cardiovascular Institute of San Diego, Chula Vista
John Muir Medical Center - Concord Campus, Concord
ak 10 plis

Ap rekriteFaz 4

Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06909565

IVUS CHIP UPP Registry

Loma Linda University Health, Loma Linda

Ap rekriteEtid obsèvasyon

Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT06625801

A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis

Thrive Clinical Research Group, LLC, Covina
Clinical Trials Research, Lincoln
University of California Irvine Medical Center - Cardiovascular Center, Los Alamitos
ak 2 plis

Ap rekriteFaz 2

Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07521007

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

National Institute of Clinical Research, Bakersfield
California Institute of Renal Research, Chula Vista
The Medical Research Group, Inc., Fresno
ak 27 plis

Ap rekriteFaz 2/3

Laj 18 ak plis · Tout sèks · Mizajou Sep 21, 2026 · NCT05485961

Product Surveillance Registry

Aliso Viejo
Chula Vista
Colton
ak 9 plis

Ap rekriteEtid obsèvasyon

Tout laj · Tout sèks · Mizajou Sep 18, 2026 · NCT01524276

Factors Affect Outcomes in Cardiovascular Surgery

University of California Davis Health System, Sacramento

Ap rekriteEtid obsèvasyon

Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT01932411

REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Minorities

Adventist Health Glendale, Glendale

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06399705

REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - Women

Adventist Health Glendale, Glendale

Ap rekriteFaz 3

Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06399692

A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease

Clinical Study Center, Pomona

Ap rekriteFaz 1

Laj 18 a 70 · Tout sèks · Mizajou Sep 2, 2026 · NCT06164730

Coronary Atherosclerosis T1-Weighted Characterization (CATCH)

Cedars-Sinai Medical Center, Los Angeles

Ap rekriteVolontè an sante akeyi

Laj 18 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT03504956

Prospective Global Registry for the Study of Chronic Total Occlusion Intervention

San Diego VAMC and University of California, San Diego

Ap rekriteEtid obsèvasyon

Tout laj · Tout sèks · Mizajou Aug 19, 2026 · NCT02061436

Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

John Muir Medical Center, Concord

Ap rekrite

Laj 18 ak plis · Tout sèks · Mizajou Jul 24, 2026 · NCT06779630

The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)

Cedars-Sinai, Los Angeles

Ap rekrite

Laj 18 ak plis · Tout sèks · Mizajou Apr 28, 2026 · NCT05427370

Prevail Global Study

Stanford Hospital & Clinics, Stanford

Ap rekrite

Laj 18 ak plis · Tout sèks · Mizajou Apr 24, 2026 · NCT06535854

The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) Trial

VA Long Beach Healthcare System, Long Beach, CA, Long Beach

Ap rekriteFaz 4

Laj 18 ak plis · Tout sèks · Mizajou Apr 22, 2026 · NCT05618353

Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women

Cedars-Sinai Medical Center, Los Angeles
Pomona Valley Hospital Medical Center, Pomona
University of California, San Francisco, San Francisco

Ap rekrite

Laj 18 ak plis · Fanm · Mizajou Apr 1, 2026 · NCT04124120

Digital Monitoring for Patients Post Coronary Interventions to Reduce Risk for Recurrent Adverse Cardiovascular Events

University of California, Davis Medical Center Division of Cardiovascular Medicine, Sacramento

Ap rekrite

Tout laj · Tout sèks · Mizajou Feb 23, 2026 · NCT06114615

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

VA Loma Linda Healthcare System, Loma Linda, CA, Loma Linda
VA Long Beach Healthcare System, Long Beach, CA, Long Beach
VA Palo Alto Health Care System, Palo Alto, CA, Palo Alto
ak 2 plis

Ap rekriteFaz 4

Laj 18 ak plis · Tout sèks · Mizajou Dec 17, 2025 · NCT02915198

MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels

Cedars-Sinai Medical Center, Los Angeles

Ap rekrite

Laj 18 a 80 · Tout sèks · Mizajou Sep 11, 2025 · NCT06271590

Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

Veteran Affairs Palo Alto Health Care System, Palo Alto
Loma Linda University, Redlands
Santa Barbara Cottage Hospital, Santa Barbara
ak 1 plis

Ap rekrite

Tout laj · Tout sèks · Mizajou Jul 24, 2025 · NCT04634240

Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel Disease

UCLA, Los Angeles
University of California, San Francisco, San Francisco

Ap rekrite

Laj 18 ak plis · Tout sèks · Mizajou Jun 19, 2025 · NCT05701358

MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

Cedars - Sinai Medical Center, Los Angeles

Ap rekrite

Laj 18 a 110 · Tout sèks · Mizajou Feb 25, 2025 · NCT05908331

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.